| __timestamp | Catalyst Pharmaceuticals, Inc. | Verona Pharma plc |
|---|---|---|
| Wednesday, January 1, 2014 | 4473654 | 1802274 |
| Thursday, January 1, 2015 | 8597010 | 2512761 |
| Friday, January 1, 2016 | 7910260 | 2894488 |
| Sunday, January 1, 2017 | 7304399 | 8096274 |
| Monday, January 1, 2018 | 15875961 | 7985229 |
| Tuesday, January 1, 2019 | 36881187 | 8994597 |
| Wednesday, January 1, 2020 | 44233754 | 29772000 |
| Friday, January 1, 2021 | 49628000 | 33907000 |
| Saturday, January 1, 2022 | 58183000 | 26579000 |
| Sunday, January 1, 2023 | 133710000 | 49868547 |
Cracking the code
In the competitive landscape of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for profitability. Over the past decade, Catalyst Pharmaceuticals, Inc. and Verona Pharma plc have showcased contrasting strategies in this domain. From 2014 to 2023, Catalyst Pharmaceuticals saw a staggering increase in SG&A expenses, peaking at approximately $134 million in 2023, a nearly 30-fold rise from 2014. In contrast, Verona Pharma's SG&A costs grew more modestly, reaching around $50 million in 2023, marking a 27-fold increase from their 2014 figures. This divergence highlights Catalyst's aggressive expansion strategy, while Verona Pharma appears to maintain a more conservative approach. Understanding these trends offers valuable insights into each company's operational priorities and financial health. As the pharmaceutical industry continues to evolve, monitoring SG&A expenses remains a key indicator of strategic direction and efficiency.
Selling, General, and Administrative Costs: Eli Lilly and Company vs Verona Pharma plc
Who Optimizes SG&A Costs Better? AbbVie Inc. or Verona Pharma plc
Operational Costs Compared: SG&A Analysis of AbbVie Inc. and Catalyst Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing United Therapeutics Corporation and Catalyst Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? Summit Therapeutics Inc. or Catalyst Pharmaceuticals, Inc.
Walgreens Boots Alliance, Inc. and Catalyst Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Axsome Therapeutics, Inc. and Catalyst Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Verona Pharma plc and ADMA Biologics, Inc.: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Verona Pharma plc vs MiMedx Group, Inc. Trends and Insights
Operational Costs Compared: SG&A Analysis of Catalyst Pharmaceuticals, Inc. and HUTCHMED (China) Limited
SG&A Efficiency Analysis: Comparing Catalyst Pharmaceuticals, Inc. and Agios Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? Catalyst Pharmaceuticals, Inc. or Wave Life Sciences Ltd.